Literature DB >> 10853650

Novel phenylpiperazine derivatives as dual cytokine regulators with TNF-alpha suppressing and IL-10 augmenting activity.

T Hanano1, K Adachi, Y Aoki, H Morimoto, Y Naka, M Hisadome, T Fukuda, H Sumichika.   

Abstract

Phenylpiperazine derivatives were synthesized as dual cytokine regulators with TNF-alpha suppressing and IL-10 augmenting activity. Lead optimization led to compound 5k having the potent regulatory activity and demonstrating remarkable protective effects against the lethal challenge of LPS in mice. suggesting that 5k would be a promising drug candidate for the treatment of TNF-alpha associated diseases including septic shock.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853650     DOI: 10.1016/s0960-894x(00)00128-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Crystal-structure studies of 4-phenyl-piperazin-1-ium 4-eth-oxy-benzoate monohydrate, 4-phenyl-piperazin-1-ium 4-meth-oxy-benzoate monohydrate, 4-phenyl-piperazin-1-ium 4-methyl-benzoate monohydrate and 4-phenyl-piperazin-1-ium tri-fluoro-acetate 0.12-hydrate.

Authors:  Ninganayaka Mahesha; Haruvegowda Kiran Kumar; Mehmet Akkurt; Hemmige S Yathirajan; Sabine Foro; Mohammed S M Abdelbaky; Santiago Garcia-Granda
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-06-10

2.  The structures of eleven (4-phen-yl)piperazinium salts containing organic anions.

Authors:  Sreeramapura D Archana; Haruvegowda Kiran Kumar; Hemmige S Yathirajan; Sabine Foro; Ray J Butcher
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-09-22

3.  4-Phenyl-piperazin-1-ium dihydrogen phosphate.

Authors:  Manel Essid; Houda Marouani; Mohamed Rzaigui; Salem S Al-Deyab
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

4.  Synthesis and crystal structures of 1-benzoyl-4-(4-nitro-phen-yl)piperazine and 1-(4-bromo-benzo-yl)-4-phenyl-piperazine at 90 K.

Authors:  Sreeramapura D Archana; Haruvegowda Kiran Kumar; Holehundi J Shankara Prasad; Hemmige S Yathirajan; Sean Parkin
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.